Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Атмосфера. Новости кардиологии
2021 / N 1

Эффективность фиксированной комбинации бисопролола и периндоприла в зависимости от используемых доз у пациентов с артериальной гипертонией и СТабИЛЬной ишемической болезнью сердца в реальной клинической практике (исследование СТИЛЬ)
С.А. Бойцов, Ю.А. Карпов, Ю.П. Бурцев, Ю.В. Хомицкая от имени всех участников исследования СТИЛЬ


References

1. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. The Lancet 2017 Jan;389(10064):37-55.
2. Leon DA, Malyutina S, Kudryavtsev AV, Voevoda M, Bobrova N, Shiekh S, Kholmatova K, McKee M, Kontsevaya A, Diez Benavente E, Bates K, Cook S. Dissecting hypertension in Russia: identifying aetiological and behavioural factors associated with treatment and control. European Journal of Public Health 2018;28(Suppl 4):299.
3. Shalnova SA, Drapkina OM. Contribution of the ESSE-RF study to preventive healthcare in Russia. Cardiovascular Therapy and Prevention 2020;19(3):209-15 (In Russian).
4. Ministry of Health of the Russian Federation. Russian Society of Cardiology. Clinical recommendations. Stable ischemic heart disease. ICD: I20.0/ I20.1/ I20.8/ I20.9/ I25.0/I25.1/ I25.2/ I25.3/ I25.4/ I25.5/ I25.6/ I25.8 I25.9. Year of approval: 2020. Age category: adults. Moscow, 2020. 114 p. Available from: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_IBS.pdf Accessed 2021 Sep 29 (In Russian).
5. Campeau L. Letter: grading of angina pectoris. Circulation 1976 Sep;54(3):522-3.
6. Pogosova NV, Boytsov SA, Oganov RG, Yufereva YuM, Kostyuk GP, Kursakov AA, Ausheva AK, Vygodin VA, Poponina TM. Clinical-epidemiological program of studying psychosocial risk factors in cardiological practice in patients with arterial hypertension and ischemic heart disease: first results of a multicenter study in Russia. Kardiologiia 2018;58(9):47-58 (In Russian).
7. Escobar E. Hypertension and coronary heart disease. Journal of Human Hypertension 2002 Mar;16(Suppl 1):S61-3.
8. Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011 Apr;123(16):1737-44.
9. Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, Abreu A, Aguiar C, Conde A, Davletov K, Dilic M, Dolzhenko M, Gaita D, Georgiev B, Gotcheva N, Lalic N, Laucevicius A, Lovic D, Mancas S, Miličić D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Vulic D, Wood D; EUROASPIRE Investigators. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. European Journal of Preventive Cardiology 2016 Dec;23(18):2007-18.
10. Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). The Lancet 2003 Sep;362(9386):782-8.
11. Bertrand ME, Ferrari R, Remme WJ, Simoons ML, Fox KM. Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: a EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis. American Heart Journal 2015 Dec;170(6):1092-8.
12. Brugts JJ, Bertrand M, Remme W, Ferrari R, Fox K, MacMahon S, Chalmers J, Simoons ML, Boersma E. The treatment effect of an ACE-inhibitor based regimen with perindopril in relation to beta-blocker use in 29,463 patients with vascular disease: a combined analysis of individual data of ADVANCE, EUROPA and PROGRESS trials. Cardiovascular Drugs & Therapy 2017 Aug;31(4):391-400.
13. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal 2018 Sep;39(33):3021-104.
14. Kobalava ZhD, Konradi AO, Nedogoda SV, Arutyunov GP, Baranova EI, Barbarash OL, Villevalde SV, Galyavich AS, Glezer MG, Drapkina OM, Kotovskaya YuV, Libis RA, Lopatin YM, Nedoshivin AO, Ostroumova OD, Ratova LG, Tkacheva ON, Chazova IE, Chesnikova AI, Chumakova GA. Russian Society of Cardiology position paper on 2018 Guidelines of the European Society of Cardiology/European Society of Arterial Hypertension for the management of arterial hypertension. Russian Journal of Cardiology 2018;23(12):131-42 (In Russian).
15. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2013 Jul;31(7):1281-357.
16. Boytsov SA, Burtsev YP, Khomitskaya YV, Karpov YuA; the STYLE study Investigators. Effectiveness and tolerability of the single-pill combination of bisoprolol and perindopril in patients with arterial hypertension and stable coronary artery disease in daily clinical practice: the STYLE study. Advances in Therapy 2021;38(6):3299-313.
17. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: the Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal 2020 Jan;41(3):407-77.
18. Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, Brunner HR, Mancia G, Schork MA, Hua TA, Holzhauer B, Zappe D, Majahalme S, Jamerson K, Koylan N. Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension. The American Journal of Cardiology 2012 Mar;109(5):685-92.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]